Seemant Raizada, Jamal Al Kandari, Khalid Al Sabti. Show Affiliations »
Abstract
Mesh: See more » Angiogenesis Inhibitors/administration & dosageAngiogenesis Inhibitors/pharmacokineticsAnimalsAntibodies, Monoclonal, Humanized/administration & dosageAntibodies, Monoclonal, Humanized/pharmacokineticsBevacizumabHumansInfant, NewbornIntravitreal InjectionsMiceRetinopathy of Prematurity/etiologyRetinopathy of Prematurity/metabolismRetinopathy of Prematurity/prevention & controlVascular Endothelial Growth Factor A/antagonists & inhibitorsVascular Endothelial Growth Factor A/metabolism
Substances: See more » Angiogenesis InhibitorsAntibodies, Monoclonal, HumanizedVEGFA protein, humanVascular Endothelial Growth Factor ABevacizumab
Year: 2011 PMID: 22127432 DOI: 10.1167/iovs.11-8479
Source DB: PubMed Journal: Invest Ophthalmol Vis Sci ISSN: 0146-0404 Impact factor: 4.799